Sort
15,273 grants matching “antimicrobial resistance”
Development of Staphylococcalcidal Human Peptides
$38,518William Maurice Shafer · Emory University · R01 · FY2008 · AI
Defining PcsB: Essential Murein Biosynthesis Protein in Pathogenic Pneumococci
$38,476Skye Barendt · Trustees Of Indiana University · F31 · FY2008 · GM
Defining PcsB: Essential Murein Biosynthesis Protein in Pathogenic Pneumococci
$38,476Skye Barendt · Trustees Of Indiana University · F31 · FY2007 · GM
Exploiting pathogen-induced cell death to create disease resistant plants:R01GM05
$38,422Jean T. Greenberg · University Of Chicago · R03 · FY2008 · TW
Cross-Kingdom Vaccine Targeting Healthcare-Associated Priority Pathogens Supplement
$38,411Ashraf S. Ibrahim · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · R01 · FY2022 · AI
Cytoskeletal Keratins in Epithelial Immunity to Bacterial Keratitis
$38,383K. P. Connie Tam · University Of California Berkeley · R01 · FY2014 · EY
Genetic regulation of antifungal drug resistance in Candida albicans
$38,334Craig Lewis Ennis · University Of California, Merced · F31 · FY2019 · DE
ANALYSIS OF CELL SIGNALING IN MULTI-SPECIES BIOFILMS
$38,320Harvard University (Medical School) · F32 · FY2002 · GM
UVPD Mass Spectrometry of Protein Complexes
$38,313Jennifer S Brodbelt · University Of Texas At Austin · R01 · FY2018 · GM
One Health Framework for Investigating Antimicrobial Resistant Enterobacterales Population Dynamics in Southwestern Virginia by Whole Genome Sequencing
$38,309Kevin K Lahmers · Virginia Polytechnic Inst And St Univ · U18 · FY2022 · FD
Defining human interferon-stimulated genes with novel functions in host defense to Chlamydia infections
$38,281Stephen Charles Walsh · Duke University · F31 · FY2021 · AI
The role of SLC11A1 in neutrophil antimicrobial response
$38,182Annica Stull-Lane · University Of California At Davis · F30 · FY2020 · AI
Defining mechanisms of complement-mediated killing of Neisseria gonorrhoeae
$38,177Evan R Lamb · University Of Virginia · F30 · FY2024 · AI
Characterizing and Exploiting Ruminococcus gnavus mediated induction of antimicrobial peptides
$38,161Zeni Elizia Ramirez · Duke University · F31 · FY2021 · AI
Investigating the role of Riboflavin and CidAB in Streptococcus mutans Anaerobic Metabolism
$38,140Matthew Turner · University Of Florida · F31 · FY2020 · DE
Human Cellular Immune Programming Against Invasive Salmonella
$38,136Rekha R Rapaka · University Of Maryland Baltimore · K08 · FY2023 · AI
A Novel Strategy to Inhibit Candida glabrata Virulence by Targeting an Essential Fungal Lipid Transfer Protein
$38,132Ashley Nicole Kidwell · Texas A&M University Health Science Ctr · F30 · FY2025 · AI
Elucidating the Role of MRSA SasF in Skin Colonization and Disease
$38,093Timothy J Enroth · University Of Colorado Denver · F31 · FY2025 · AI
Interactions between Pseudomonas aeruginosa and Streptococcus salivarius and effects on the host immune response
$38,042Sara N Stoner · University Of Alabama At Birmingham · F31 · FY2022 · HL
New Genetic Tools for Accessing Anti-Infective Agents from Gram-Negative Bacteria
$38,024Jamie Zhang · University Of California, San Diego · F31 · FY2018 · AI
S. mutans: Its mutacin Antibiotic
$37,951Fengxia Qi · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2006 · DE
Development of novel bacteriophage-based therapies to combat Pseudomonas aeruginosa and Candida spp. dual-species biofilms.
$37,923Charlton Lam · Ohio State University · F31 · FY2025 · AI
Proteomic approach to identify mediators of PI3K activation by P. aeruginosa
$37,901Joanne N. Engel · University Of California, San Francisco · R03 · FY2009 · TW
Proteomic approach to identify mediators of PI3K activation by P. aeruginosa
$37,901Joanne N. Engel · University Of California, San Francisco · R03 · FY2010 · TW
Proteomic approach to identify mediators of PI3K activation by P. aeruginosa
$37,901Joanne N. Engel · University Of California, San Francisco · R03 · FY2008 · TW